The OTC drug industry has another state legislation target to regularly track while also continuing to search in unlikely places for proposals with potential impact on manufacturing and marketing its products.
States’ Cosmetic Ingredient Legislation Also Touching Drugs Gets CHPA's Highlight Treatment
Bills Affecting Consumer Health Industry Also Found Concealed Around State Legislatures
“Lawmakers are not distinguishing between a cosmetic drug and a cosmetic that has no drug application at all,” says Carlos Gutierrez, CHPA’s state legislature lobby chief. Issues important to consumer health products industry can be found in unlikely places, he also tells HBW Insight.
